Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Accounting Officer

Chief Executive Officer

Chief Financial Officer

General Counsel

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology pl...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-09	Premium	sold	Premium	Premium	Premium	-
2023-11-22	Premium	bought	Premium	Premium	Premium	Chief Accounting Officer
2023-11-21	Premium	bought	Premium	Premium	Premium	Chief Accounting Officer
2023-08-09	Premium	acquired	Premium	Premium	Premium	-
2023-08-09	Premium	acquired	Premium	Premium	Premium	-
2023-08-09	Premium	bought	Premium	Premium	Premium	-
2023-08-09	Premium	bought	Premium	Premium	Premium	-
2023-08-09	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-08-09	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-08-09	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-03-17	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2021-11-09	Premium	bought	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	-
2021-11-09	Premium	bought	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2021-11-09	Premium	bought	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	-
2021-11-09	Premium	bought	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	-
2021-11-09	Premium	bought	Premium	Premium	Premium	-
2021-11-09	Premium	bought	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	-
2021-11-09	Premium	acquired	Premium	Premium	Premium	-
2021-11-09	Premium	bought	Premium	Premium	Premium	-

IOBT - IO Biotech, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for IOBT